top of page
it's where dermatology lives




1/2


72% of AD patients report poor mental health symptoms for one to 10 days in the previous month
A survey from the National Eczema Association in the U.S. has revealed that patients with AD tend to experience poor mental health symptoms.
Allan Ryan
Nov 13, 20231 min read


VIDEO: Patch tests for allergic contact dermatitis still effective in AD patients on dupilumab
The use of dupilumab in patients with AD did not significantly affect the results of patch tests for allergic contact dermatitis.
Jeremy Visser
Nov 8, 20231 min read


New bacteriophages identified in skin microbiome
A research study from Vienna has reported that bacteriophages found in the skin microbiome of patients with AD may lead to the...
John Evans
Oct 23, 20231 min read


Barriers to care for U.S. sexual and gender minority patients with inflammatory skin disease
Findings from a cross-sectional study of survey data suggest that U.S. sexual and gender minority (SGM) patients with chronic...
John Evans
Oct 20, 20232 min read


VIDEO: Colloidal oatmeal as efficacious as barrier cream in Black children with AD
Colloidal oatmeal 1% is efficacious in treating mild-to-moderate AD in Black children, according to a recent study.
Jeremy Visser
Oct 18, 20231 min read


EADV 2023 Day 2 Evening: Molecular Signature of Chronic Hand Eczema
Dr. Vimal Prajapati reports on common molecular signatures of chronic hand eczema at the 2023 EADV Congress in Berlin.
Jeremy Visser
Oct 13, 20231 min read


EADV 2023 Day 2 Afternoon: Treating Severe Atopic Dermatitis with Tapinarof 1% Cream
Dr. Vimal Prajapati reports about tapinarof 1% cream for treating severe AD at the 2023 EADV Congress in Berlin.
Jeremy Visser
Oct 13, 20231 min read


EADV 2023 Day 1 Evening: Late Breakers in Atopic Dermatitis
Dr. Mark Kirchhof reports late breakers presentations around atopic dermatitis and prurigo nodularis from the 2023 EADV Congress in Berlin.
Jeremy Visser
Oct 12, 20231 min read
Featured Posts


bottom of page
